Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Jones

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
JCO Clinical Cancer Informatics|October 30, 2020
Population Heath Informatics Can Advance Interoperability: National Program of Cancer Registries Electronic Pathology Reporting ProjectLori A Pollack, Sandra F Jones, Wendy Blumenthal, et al.
Hepatology Communications|February 19, 2025
Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER studyHelen T Smith, Sugato Das, James Fettiplace, et al.
Neurology. Clinical Practice|January 7, 2017
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic reviewMatthew H Sutliff, Susan E Bennett, Patricia Bobryk, et al.
Hepatology Communications|March 31, 2025
Erratum: Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER studyHelen T Smith, Sugato Das, James Fettiplace, et al.
BMJ Open|August 23, 2015
RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trialLaura Jopson, Julia L Newton, Jeremy Palmer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2021
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon Hirschfield, et al.
Hepatology Communications|June 9, 2018
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitisMarco Carbone, Maren H Harms, Willem J Lammers, et al.
JCO Clinical Cancer Informatics|January 7, 2021
Pursuing Data Modernization in Cancer Surveillance by Developing a Cloud-Based Computing Platform: Real-Time Cancer Case CollectionDavid E Jones, Temitope O Alimi, Paran Pordell, et al.
Toxicology Letters|January 8, 2016
Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanismPhilip M Probert, Jeremy M Palmer, Wasma Alhusainy, et al.
Hepatology (Baltimore, Md.)|December 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
JCO Clinical Cancer Informatics|October 30, 2020
Population Heath Informatics Can Advance Interoperability: National Program of Cancer Registries Electronic Pathology Reporting ProjectLori A Pollack, Sandra F Jones, Wendy Blumenthal, et al.
Hepatology Communications|February 19, 2025
Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER studyHelen T Smith, Sugato Das, James Fettiplace, et al.
Neurology. Clinical Practice|January 7, 2017
Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic reviewMatthew H Sutliff, Susan E Bennett, Patricia Bobryk, et al.
Hepatology Communications|March 31, 2025
Erratum: Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER studyHelen T Smith, Sugato Das, James Fettiplace, et al.
BMJ Open|August 23, 2015
RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trialLaura Jopson, Julia L Newton, Jeremy Palmer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 17, 2021
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon Hirschfield, et al.
Hepatology Communications|June 9, 2018
Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitisMarco Carbone, Maren H Harms, Willem J Lammers, et al.
JCO Clinical Cancer Informatics|January 7, 2021
Pursuing Data Modernization in Cancer Surveillance by Developing a Cloud-Based Computing Platform: Real-Time Cancer Case CollectionDavid E Jones, Temitope O Alimi, Paran Pordell, et al.
Toxicology Letters|January 8, 2016
Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1'-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanismPhilip M Probert, Jeremy M Palmer, Wasma Alhusainy, et al.
Hepatology (Baltimore, Md.)|December 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitisAndreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield, et al.
Pageof 11